218 related articles for article (PubMed ID: 23738749)
1. Edelfosine and miltefosine effects on lipid raft properties: membrane biophysics in cell death by antitumor lipids.
Castro BM; Fedorov A; Hornillos V; Delgado J; Acuña AU; Mollinedo F; Prieto M
J Phys Chem B; 2013 Jul; 117(26):7929-40. PubMed ID: 23738749
[TBL] [Abstract][Full Text] [Related]
2. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-tumor ether lipids on ordered domains in model membranes.
Heczková B; Slotte JP
FEBS Lett; 2006 May; 580(10):2471-6. PubMed ID: 16638573
[TBL] [Abstract][Full Text] [Related]
4. Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
Vink SR; van der Luit AH; Klarenbeek JB; Verheij M; van Blitterswijk WJ
Biochem Pharmacol; 2007 Nov; 74(10):1456-65. PubMed ID: 17803969
[TBL] [Abstract][Full Text] [Related]
5. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
6. Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria.
Mollinedo F; Fernández M; Hornillos V; Delgado J; Amat-Guerri F; Acuña AU; Nieto-Miguel T; Villa-Pulgarín JA; González-García C; Ceña V; Gajate C
Cell Death Dis; 2011 May; 2(5):e158. PubMed ID: 21593790
[TBL] [Abstract][Full Text] [Related]
7. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts.
Gajate C; Mollinedo F
Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375
[TBL] [Abstract][Full Text] [Related]
8. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
[TBL] [Abstract][Full Text] [Related]
9. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells.
Gajate C; Gonzalez-Camacho F; Mollinedo F
PLoS One; 2009; 4(4):e5044. PubMed ID: 19352436
[TBL] [Abstract][Full Text] [Related]
10. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
11. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells.
van der Luit AH; Vink SR; Klarenbeek JB; Perrissoud D; Solary E; Verheij M; van Blitterswijk WJ
Mol Cancer Ther; 2007 Aug; 6(8):2337-45. PubMed ID: 17699729
[TBL] [Abstract][Full Text] [Related]
12. Edelfosine is incorporated into rafts and alters their organization.
Ausili A; Torrecillas A; Aranda FJ; Mollinedo F; Gajate C; Corbalán-García S; de Godos A; Gómez-Fernández JC
J Phys Chem B; 2008 Sep; 112(37):11643-54. PubMed ID: 18712919
[TBL] [Abstract][Full Text] [Related]
13. Lipid raft-targeted therapy in multiple myeloma.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; Campanero MA; Blanco-Prieto MJ
Oncogene; 2010 Jul; 29(26):3748-57. PubMed ID: 20418917
[TBL] [Abstract][Full Text] [Related]
14. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
15. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
[TBL] [Abstract][Full Text] [Related]
16. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
17. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast.
Cuesta-Marbán Á; Botet J; Czyz O; Cacharro LM; Gajate C; Hornillos V; Delgado J; Zhang H; Amat-Guerri F; Acuña AU; McMaster CR; Revuelta JL; Zaremberg V; Mollinedo F
J Biol Chem; 2013 Mar; 288(12):8405-8418. PubMed ID: 23335509
[TBL] [Abstract][Full Text] [Related]
18. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis.
Ruiter GA; Verheij M; Zerp SF; van Blitterswijk WJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):415-9. PubMed ID: 11173135
[TBL] [Abstract][Full Text] [Related]
19. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.
Gajate C; Gonzalez-Camacho F; Mollinedo F
Biochem Biophys Res Commun; 2009 Mar; 380(4):780-4. PubMed ID: 19338752
[TBL] [Abstract][Full Text] [Related]
20. Effects of the anti-neoplastic agent ET-18-OCH3 and some analogs on the biophysical properties of model membranes.
Torrecillas A; Aroca-Aguilar JD; Aranda FJ; Gajate C; Mollinedo F; Corbalán-García S; de Godos A; Gómez-Fernández JC
Int J Pharm; 2006 Aug; 318(1-2):28-40. PubMed ID: 16624506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
